This activity has expired.

Pregnancy and Obesity

Release Date: December 15, 2015
Expiration Date: October 11, 2016

Intended Audience

Physicians, Nurse Practitioners, Registered Nurses, Registered Dietitians .

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • To identify and modify potential early risk factors for health promotion and disease prevention
  • To understand extra-genetic mechanisms as determinants of obesity in women and children
  • Provide insights into recent studies related to weight management during pregnancy

Statement of Need

As the obesity epidemic progresses, healthcare professionals should look toward educational forums to learn about the most modern advances in research, treatment, and best business practices to improve the quality of life for individuals who are obese and overweight. The conference promotes educational advancement by merging academic and clinical experts with professionals, and provides an opportunity for networking and the exchange of indispensable knowledge

Method of Participation

This activity should take approximately one hour to complete. Participants should first read the objectives and other introductory CME/CE information and then proceed to the educational activity. To receive credit for this activity, participants must complete the post-test with a passing score of 80% and then complete the evaluation. Credit is provided through December 15, 2016. No credit will be given after this date. There is no fee to participate in this activity.

In the event you have questions about this activity or are unable to retrieve the certificate, please email and a certificate will be emailed within 2 weeks.

System requirements

  • Computer, tablet, or smart phone with internet access
  • Web browser (IE 8.0+ or Webkit/Mozilla Compatible) with Javascript enabled
  • HTML5 compatible browser or Adobe Flash Player


Dannemiller is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Dannemiller designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registered Nurses

Dannemiller is a provider approved by the California Board of Registered Nursing, Provider Number 4229 for 1.00 contact hours. CBRN credit is not accepted by the Michigan and Utah State licensing boards.

Nurse Practitioners

Dannemiller is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 090419. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. It provides 1.00 contact hours of continuing education.

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for completing this program.

Registered Dietitians

Dannemiller is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.00 continuing professional education units (CPEUs) for completion of this material. CDR Provider #DM002. Level 1 Provided.

Participants can contact the CDR to evaluate the quality of the educational activity materials at or in writing to CDR, 120 South Riverside Plaza, Suite 2000, Chicago, IL, 60606.


Gitanjali Srivastava, MD, FAAP, FACP

Medical Director, CHOMLI and The Center for Obesity Medicine at Florida Hospital 


In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest.

The following faculty stated they have no relevant financial disclosure:

  • Gitanjali Srivastava, MD, FAAP, FACP

Dr. Bernard Abrams, content reviewer and Gordon Ringler, Dannemiller project manager have no financial relationships with commercial interests.

To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence based and commercially balanced.

Off-label statement

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.